BBR Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.08M | Buy |
8,983
+400
| +5% | +$46.2K | 0.06% | 102 |
|
|
2025
Q4 | $903K | Sell |
8,583
-76
| -0.9% | -$7.13K | 0.05% | 118 |
|
|
2025
Q3 | $727K | Buy |
8,659
+81
| +0.9% | +$6.67K | 0.04% | 125 |
|
|
2025
Q2 | $679K | Sell |
8,578
-540
| -6% | -$42.9K | 0.04% | 122 |
|
|
2025
Q1 | $818K | Sell |
9,118
-101
| -1% | -$9.43K | 0.06% | 108 |
|
|
2024
Q4 | $917K | Sell |
9,219
-795
| -8% | -$82K | 0.06% | 101 |
|
|
2024
Q3 | $1.14M | Sell |
10,014
-231
| -2% | -$27.4K | 0.09% | 81 |
|
|
2024
Q2 | $1.27M | Sell |
10,245
-5,554
| -35% | -$715K | 0.1% | 68 |
|
|
2024
Q1 | $2.08M | Buy |
15,799
+2,776
| +21% | +$342K | 0.17% | 59 |
|
|
2023
Q4 | $1.42M | Sell |
13,023
-470
| -3% | -$48.8K | 0.15% | 58 |
|
|
2023
Q3 | $1.39M | Sell |
13,493
-8,298
| -38% | -$894K | 0.16% | 54 |
|
|
2023
Q2 | $2.51M | Sell |
21,791
-255
| -1% | -$29K | 0.28% | 39 |
|
|
2023
Q1 | $2.35M | Buy |
22,046
+639
| +3% | +$69K | 0.27% | 38 |
|
|
2022
Q4 | $2.38M | Hold |
21,407
| – | – | 0.27% | 37 |
|
|
2022
Q3 | $1.84M | Sell |
21,407
-5,541
| -21% | -$495K | 0.24% | 47 |
|
|
2022
Q2 | $2.46M | Hold |
26,948
| – | – | 0.29% | 43 |
|
|
2022
Q1 | $2.21M | Buy |
26,948
+10,000
| +59% | +$788K | 0.21% | 58 |
|
|
2021
Q4 | $1.3M | Sell |
16,948
-1,333
| -7% | -$106K | 0.15% | 73 |
|
|
2021
Q3 | $1.37M | Buy |
18,281
+1,625
| +10% | +$124K | 0.11% | 72 |
|
|
2021
Q2 | $1.29M | Sell |
16,656
-1,985
| -11% | -$148K | 0.1% | 76 |
|
|
2021
Q1 | $1.37M | Buy |
18,641
+614
| +3% | +$45.3K | 0.11% | 74 |
|
|
2020
Q4 | $1.41M | Buy |
18,027
+139
| +0.8% | +$10.6K | 0.12% | 68 |
|
|
2020
Q3 | $1.42M | Sell |
17,888
-17,012
| -49% | -$1.33M | 0.12% | 68 |
|
|
2020
Q2 | $2.58M | Sell |
34,900
-10,563
| -23% | -$795K | 0.33% | 32 |
|
|
2020
Q1 | $3.34M | Sell |
45,463
-2,106
| -4% | -$166K | 0.5% | 22 |
|
|
2019
Q4 | $4.13M | Buy |
+47,569
| New | +$3.91M | 0.45% | 25 |
|
|
2019
Q2 | – | Sell |
-2,579
| Closed | -$205K | – | 133 |
|
|
2019
Q1 | $205K | Sell |
2,579
-516
| -17% | -$38.6K | 0.03% | 125 |
|
|
2018
Q4 | $226K | Buy |
+3,095
| New | +$218K | 0.03% | 125 |
|
|
2015
Q3 | – | Sell |
-798,161
| Closed | -$43.4M | – | 74 |
|
|
2015
Q2 | $43.4M | Hold |
798,161
| – | – | 5.36% | 3 |
|
|
2015
Q1 | $43.8M | Sell |
798,161
-8
| -0% | -$453 | 5.92% | 3 |
|
|
2014
Q4 | $43.3M | Buy |
+798,169
| New | +$44.5M | 5.79% | 3 |
|
|
2014
Q3 | – | Sell |
-798,161
| Closed | -$44.1M | – | 66 |
|
|
2014
Q2 | $44.1M | Hold |
798,161
| – | – | 6.76% | 3 |
|
|
2014
Q1 | $43.2M | Sell |
798,161
-220,080
| -22% | -$11.4M | 7.12% | 3 |
|
|
2013
Q4 | $48.6M | Hold |
1,018,241
| – | – | 8.74% | 3 |
|
|
2013
Q3 | $46.3M | Sell |
1,018,241
-108,873
| -10% | -$4.97M | 9.38% | 3 |
|
|
2013
Q2 | $50M | Buy |
+1,127,114
| New | +$50.3M | 9.75% | 3 |
|
Other funds holding MRK
VCM
VPM
BBR Partners's MRK Position: Q1 2026 in Review
BBR Partners increased its Merck (MRK) stake by 4.7% in Q1 2026, buying an estimated $46.2K and bringing the position to 8,983 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #102.
BBR Partners first reported a position in MRK in Q2 2013 and has held it in 36 quarters since. The position peaked at $50M in Q2 2013. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- BBR Partners held 8,983 shares of Merck worth $1.08M as of Q1 2026.
- BBR Partners bought 400 Merck shares in Q1 2026, an estimated $46.2K.
- Merck made up 0.06% of BBR Partners's portfolio in Q1 2026, its #102 holding.
- BBR Partners first reported a position in Merck in Q2 2013 and has held it in 36 quarters since.
- BBR Partners's Merck position peaked at $50M in Q2 2013.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on BBR Partners's 13F filing for Q1 2026, filed 12 May 2026.